Marie L. Kronke-Hutter
Steglitz Bezirk, BE, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications
Rapid and profound treatment response of difficult-to-treat rheumatoid arthritis to CD19 CAR T-cell therapy.
Journal: EULAR rheumatology open
Published: August 01, 2026
Blinatumomab in refractory SLE-associated immune thrombocytopenia.
Journal: Annals of the rheumatic diseases
Published: July 01, 2026
Teclistamab induces rapid clinical response and deep tissue depletion in refractory systemic sclerosis-a case series.
Journal: Annals of the rheumatic diseases
Published: January 19, 2026
Teclistamab for treatment-refractory autoimmune diseases: a multicentre case series.
Journal: Annals of the rheumatic diseases
Published: January 19, 2026
Teclistamab-induced rapid remission in refractory Anti-Jo-1 Antisynthetase Syndrome.
Journal: Annals of the rheumatic diseases
Published: September 07, 2025
Targeting autoimmunity with CD19-CAR T-cell therapy: efficacy and seroconversion in diffuse systemic sclerosis and rheumatoid arthritis.
Journal: Rheumatology (Oxford, England)
Published: December 11, 2024
Anti-CD19 CAR T cell therapy induces antibody seroconversion and complete B cell depletion in the bone marrow of a therapy-refractory patient with ANCA-associated vasculitis.
Journal: Annals of the rheumatic diseases
Published: September 17, 2024
Comparable CD8+ T-cell responses to SARS-CoV-2 vaccination in single-cell transcriptomics of recently allogeneic transplanted patients and healthy individuals.
Journal: Journal of medical virology
Published: November 29, 2023
Phase I/Ib, open-label, multicenter, dose-escalation study of the anti-TGF-β monoclonal antibody, NIS793, in combination with spartalizumab in adult patients with advanced tumors.
Journal: Journal for immunotherapy of cancer
Published: August 28, 2023
Last Updated: 09/26/2026